Combined millimeter wave and cyclophosphamide therapy of an experimental murine melanoma

The objective of the present studies was to investigate whether millimeter wave (MMW) therapy can increase the efficacy of cyclophosphamide (CPA), a commonly used anti-cancer drug. The effect of combined MMW-CPA treatment on melanoma growth was compared to CPA treatment alone in a murine model. MMWs were produced with a Russian made YAV-1 generator. The device produced 42.2 +/- 0.2 GHz modulated wave radiation through a 10 x 20 mm rectangular output horn. The animals, SKH-1 hairless female mice, were irradiated on the nasal area. Peak SAR and incident power density were measured as 730 +/- 100 W/kg and 36.5 +/- 5 mW/cm2, respectively. The maximum skin surface temperature elevation measured at the end of 30 min irradiation was 1.5 degrees C. B16F10 melanoma cells (0.2 x 10(6)) were implanted subcutaneously into the left flank of mice on day 1 of the experiment. On days 4-8, CPA was administered intraperitoneally (30 mg/kg/day). MMW irradiation was applied concurrently with, prior to or following CPA administration. A significant reduction (P < .05) in tumor growth was observed with CPA treatment, but MMW irradiation did not provide additional therapeutic benefit as compared to CPA alone. Similar results were obtained when MMW irradiation was applied both prior to and following CPA treatment.

[1]  Alexis Agelan,et al.  Effect of millimeter waves on cyclophosphamide induced suppression of the immune system , 2002, Bioelectromagnetics.

[2]  Colvin Om.  An overview of cyclophosphamide development and clinical applications. , 1999 .

[3]  M C Ziskin,et al.  Medical application of millimetre waves. , 1998, QJM : monthly journal of the Association of Physicians.

[4]  D. Longo,et al.  Chemoprotective effects of recombinant human IL-1 alpha in cyclophosphamide-treated normal and tumor-bearing mice. Protection from acute toxicity, hematologic effects, development of late mortality, and enhanced therapeutic efficacy. , 1990, Journal of immunology.

[5]  M. Ziskin,et al.  Effect of millimeter waves on cyclophosphamide induced suppression of T cell functions , 2003, Bioelectromagnetics.

[6]  O. V. Betskiy.  Millimeter waves in biology and medicine : (a review) , 1993 .

[7]  D. Carvajal,et al.  Administration of recombinant interleukin-12 to mice suppresses hematopoiesis in the bone marrow but enhances hematopoiesis in the spleen. , 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[8]  Y. Kumazawa,et al.  Accelerated recovery from cyclophosphamide-induced leukopenia in mice administered a Japanese ethical herbal drug, Hochu-ekki-to. , 1999, Immunopharmacology.

[9]  C. Kruse,et al.  Chemo-immunotherapy and chemo-adoptive immunotherapy of cancer. , 2001, Cancer treatment reviews.

[10]  A. Dabrowska,et al.  Augmented antitumor effects of combination therapy with interleukin-12, cisplatin, and tumor necrosis factor-alpha in a murine melanoma model. , 1997, Anticancer research.

[11]  P. Philip,et al.  Biochemotherapy for melanoma. , 2002, Current oncology reports.

[12]  S. Narula,et al.  A specific stimulator of granulocyte colony-stimulating factor accelerates recovery from cyclophosphamide-induced neutropenia in the mouse. , 1997, Blood.

[13]  C. Leonetti,et al.  Antitumor and antimetastatic effects of dacarbazine combined with cyclophosphamide and interleukin-2 in Lewis lung carcinoma (3LL) , 1995, Cancer Immunology, Immunotherapy.

[14]  A. Pakhomov,et al.  Low-intensity millimeter waves as a novel therapeutic modality , 1999, Digest of Technical Papers. 12th IEEE International Pulsed Power Conference. (Cat. No.99CH36358).

[15]  M. J. Ehrke,et al.  Cyclophosphamide plus tumor necrosis factor‐α chemoimmunotherapy cured mice: Life‐long immunity and rejection of re‐implanted primary lymphoma , 1995, International journal of cancer.

[16]  A. Schrader.  Combined chemoimmunotherapy in metastatic melanoma - is there a need for the double? , 2000, Anti-cancer drugs.

[17]  J. Jackson,et al.  Interleukin-12 enhances peripheral hematopoiesis in vivo. , 1995, Blood.

[18]  K. Yamauchi,et al.  Nucleoside-nucleotide mixture increases peripheral neutrophils in cyclophosphamide-induced neutropenic mice. , 1995, Nutrition.

[19]  E. Kedar,et al.  Chemo-immunotherapy of murine tumors using interleukin-2 (IL-2) and cyclophosphamide , 1989, Cancer Immunology, Immunotherapy.

[20]  Y. Ueyama,et al.  Timing of recombinant human granulocyte colony-stimulating factor administration on neutropenia induced by cyclophosphamide in normal mice. , 1998, British Journal of Cancer.

[21]  M C Ziskin,et al.  Local heating of human skin by millimeter waves: A kinetics study , 2003, Bioelectromagnetics.

[22]  M. Moore,et al.  Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[23]  V. Peterson,et al.  Recombinant human interleukin-1 receptor antagonist protects early myeloid progenitors in a murine model of cyclophosphamide-induced myelotoxicity. , 1995, Blood.

[24]  B. Ryffel,et al.  The stimulatory effects of interleukin (IL)-12 on hematopoiesis are antagonized by IL-12-induced interferon gamma in vivo , 1995, The Journal of experimental medicine.

[25]  A Cowan,et al.  Hypoalgesic effect of millimeter waves in mice: dependence on the site of exposure. , 2000, Life sciences.

[26]  M. Ziskin,et al.  In Vivo Effects of Millimeter Waves on Cellular Immunity of Cyclophosphamide-Treated Mice , 1997 .